Rein Therapeutics Inc Stock (RNTX) Forecast
The Rein Therapeutics Inc (RNTX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $1.09, representing a +75.56% increase from the current price of $0.6209. The highest analyst price target is $1.61, and the lowest is $0.5693.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month RNTX Price Target
Average 0.8077 (+30.09% Upside)
Is Rein Therapeutics Inc (RNTX) A Buy Now?
Oscillators
Buy: 1 · Sell: 0 · Neutral: 6Summary: Neutral
Moving Averages
Buy: 0 · Sell: 10 · Neutral: 0Summary: Sell
According to our latest analysis, RNTX could be considered a Strong Sell, with 17 technical analysis indicators signaling 1 Buy signals, 10 signaling Sell signals and 6 Neutral signals. This might not be a good time to consider opening new positions on RNTX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 43.36 indicates that RNTX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 44.20 indicates that RNTX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 41.49 indicates that RNTX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of 17.42 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of -39.18 indicates that RNTX is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term RNTX price forecast for 2026, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Rein Therapeutics Inc financial reports and earnings history, Rein Therapeutics Inc (RNTX) stock could reach $2.14 by 2030, $4.99 by 2040 and $10.90 by 2050. See the projected annual prices until 2050 of the Rein Therapeutics Inc stock below:
- Rein Therapeutics Inc (RNTX) is expected to reach an average price of $3.12 in 2035, with a high prediction of $4.58 and a low estimate of $3.24. This indicates an +402.89% change from the last recorded price of $0.6209.
- Rein Therapeutics Inc (RNTX) stock is projected to chart a bullish course in 2040, with an average price target of $2.62, representing an +322.07% change from its current level. The forecast ranges from a conservative $2.53 to a sky-high $4.99.
- Our analysts predict Rein Therapeutics Inc (RNTX) to change +1,300% by 2045, soaring from $3.31 to an average price of $8.69, potentially reaching $11.90. While $3.31 is the low estimate, the potential upside is significant.
- Rein Therapeutics Inc (RNTX) stock is expected to climb by 2050, reaching an average of $5.73, a +823.45% change from its current level. However, a wide range of estimates exists, with high and low targets of $10.90 and $5.73, respectively, highlighting the market's uncertainty.
Rein Therapeutics Inc Stock (RNTX) Year by Year Forecast
Rein Therapeutics Inc Stock (RNTX) Price Forecast for 2026
The predicted value for Rein Therapeutics Inc (RNTX) in 2026 is set at an average of $0.9623. Estimates vary from a peak of $2.12 to a trough of $0.4446, indicating an +54.99% surge from the present price of $0.6209.
Rein Therapeutics Inc Stock (RNTX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Rein Therapeutics Inc (RNTX) is $0.4258, with a high forecast of $1.22 and a low forecast of $0.00454. This indicates an -31.42% decrease from the last price of $0.6209.
Rein Therapeutics Inc Stock (RNTX) Price Forecast for 2028
In 2028, Rein Therapeutics Inc (RNTX) is projected to reach an average price of $0.3724, with a high projection of $1.38 and a low estimate of $0.0814. This indicates an -40.02% fall from the last price of $0.6209.
Rein Therapeutics Inc Stock (RNTX) Price Forecast for 2029
The 2029 price forecast for Rein Therapeutics Inc Stock (RNTX) is $0.7055 on average, with a high prediction of $1.02 and a low estimate of $0.4621. This represents an +13.63% increase from the previous price of $0.6209.
Rein Therapeutics Inc Stock (RNTX) Price Forecast for 2030
Rein Therapeutics Inc Stock (RNTX) is expected to reach an average price of $0.4102 in 2030, with a high forecast of $2.14 and a low forecast of $0.0482. This signifies an -33.94% decrease from the last price of $0.6209.
